News / Events All that is new

NanoVibronix Reports Significant Progress with a Leading Global Consumer Healthcare Company ELMSFORD, N.Y., Aug. 27, 2019 /PRNewswire/ –NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the PainShield® surface acoustic wave (SAW) device, today announced significant progress with a leading global consumer healthcare company, Medisana, which has…

NANOVIBRONIX SIGNS DISTRIBUTION AGREEMENT WITH PROTRADE SYSTEMS FOR PAINSHIELD® MD. ELMSFORD, NY / ACCESSWIRE / August 13, 2019 / NanoVibronix, Inc., (NASDAQ:NAOV), a medical device company that produces the PainShield® surface acoustic wave (SAW) device, which utilizes the Company’s proprietary and patented low intensity, SAW (Surface Acoustic Wave)…

NANOVIBRONIX ANNOUNCES LICENSE AGREEMENT WITH IDEAL MEDICAL INTERNATIONAL LIMITED FOR INTERNATIONAL DISTRIBUTION OF PAINSHIELD® AND UROSHIELD®. ELMSFORD, NY / ACCESSWIRE / July 23, 2019 / NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the PainShield® surface acoustic wave (SAW) device, which utilizes the Company’s proprietary and patented low intensity, SAW ultrasound technology, today announced…

NanoVibronix Announces Planned Launch of CBD Patch and Cream for PainShield® Designed to Amplify Therapeutic Effect. ELMSFORD, NY / ACCESSWIRE / June 3, 2019 / NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the PainShield® surface acoustic wave (SAW) device, which utilizes the Company’s proprietary and patented low intensity, SAW ultrasound technology, today…

NANOVIBRONIX ANNOUNCES REIMBURSEMENT APPROVALS FOR PAINSHIELD® IN THE U.S. ELMSFORD, NY / ACCESSWIRE / March 25, 2019 / NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that it has begun receiving reimbursement…

3 Most Common Trigeminal Nerve Pain Relief Methods Anyone who has ever suffered from trigeminal neuralgia can confirm that it is the most excruciating feeling of pain known to man. The American Association of Neurological Surgeons gives more credence to that statement as it describes…

NANOVIBRONIX ANNOUNCES EXCLUSIVE AGREEMENT FOR DISTRIBUTION OF PAINSHIELD® AND UROSHIELD® IN ITALY ELMSFORD, NY / ACCESSWIRE / March 20, 2019 / NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has entered into an…

NANOVIBRONIX REPORTS POSITIVE INTERIM TENNIS ELBOW STUDY RESULTS USING PAINSHIELD® ELMSFORD, NY / ACCESSWIRE / March 7, 2019 / NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced results of a study entitled, “The…

The Qualities of an Ideal Ultrasound Therapy Machine Ultrasound therapy machines have been in use in the medical field of physiotherapy since at least the 1940s. Therapists use it on the skin to apply deep heat or mechanical vibrations to soft issues to treat a…

NanoVibronix Announces Publication of PainShield™ Trigeminal Neuralgia Study in the Journal of Anesthesiology and Pain Research ELMSFORD, N.Y., Feb. 25, 2019 (GLOBE NEWSWIRE) — NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced the publication of an independent study entitled, “The…

NANOVIBRONIX ENTERS COLLABORATION AGREEMENT WITH FRITZ CLINIC TO OFFER PAINSHIELD® AS AN ALTERNATIVE TO OPIOIDS FOR PAIN MANAGEMENT ELMSFORD, N.Y., Jan. 11, 2019 (GLOBE NEWSWIRE) — NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that it has entered into a collaboration agreement…

NANOVIBRONIX ANNOUNCES EXPANDED AGREEMENT WITH MDS PHARM LTD. TO INCLUDE DISTRIBUTION OF UROSHIELD® IN ISRAEL ELMSFORD, N.Y., Dec. 27, 2018 (GLOBE NEWSWIRE) — NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has expanded its distribution agreement with…

NANOVIBRONIX SIGNS MAJOR DISTRIBUTOR IN INDIA FOR UROSHIELD® ELMSFORD, N.Y., Dec. 20, 2018 (GLOBE NEWSWIRE) — NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced, in partnership with Morulaa HealthTech, NanoVibronix’s marketing partner…

NANOVIBRONIX SIGNS WITH EXCLUSIVE DISTRIBUTOR IN SWITZERLAND FOR UROSHIELD® ELMSFORD, N.Y., Dec. 18, 2018 (GLOBE NEWSWIRE) — NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has signed a new distribution agreement for…

NANOVIBRONIX ANNOUNCES SELECTION OF LEADING INTERNATIONAL CONTRACT MANUFACTURER TO SUPPORT RAPID SCALE-UP, LOWER PRICE POINTS AND ENHANCE PROFITABILITY ELMSFORD, N.Y., Dec. 11, 2018 (GLOBE NEWSWIRE) — NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has appointed Quasar as its contract manufacturer…

NANOVIBRONIX ANNOUNCES PUBLICATION OF STUDY MEASURING THE EFFECT OF SURFACE ACOUSTIC WAVES ON BACTERIAL LOAD AND PREVENTING CATHETER-ASSOCIATED URINARY TRACT INFECTIONS UroShield™ reduced Colony Forming Units (CFU) count from >100,000 to 10,000 CFU or less in 25 of 29 patients in the treatment group No reported infections in the treatment group versus 27% symptomatic treated infections in the…

NANOVIBRONIX PROVIDES BUSINESS UPDATE FOR THE THIRD QUARTER OF 2018 Lays out key upcoming milestones for the next 12 months ELMSFORD, N.Y., Nov. 14, 2018 (GLOBE NEWSWIRE) — NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology,…

NANOVIBRONIX TO PRESENT AT DAWSON JAMES SECURITIES 4TH ANNUAL SMALL CAP GROWTH CONFERENCE ELMSFORD, N.Y., Oct. 22, 2018 (GLOBE NEWSWIRE) — NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that Brian Murphy, Chief Executive Officer, will…

NANOVIBRONIX CEO BRIAN MURPHY AND FORMER MLB PITCHER BRET SABERHAGEN TO APPEAR TODAY ON VARNEY & CO. ON FOX BUSINESS TO DISCUSS PAINSHIELD Both to appear tomorrow as guests on KTLA Morning News in Los Angeles ELMSFORD, N.Y., Oct. 22, 2018 (GLOBE NEWSWIRE) — NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic…

NANOVIBRONIX PROVIDES BUSINESS UPDATE FOR THE SECOND QUARTER OF 2018 ELMSFORD, N.Y., Aug. 16, 2018 (GLOBE NEWSWIRE) — NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today provided a business update for the second quarter ended…

NANOVIBRONIX REPORTS SUCCESSFUL TRIAL RESULTS FOR USE OF PAINSHIELD™ IN PATIENTS WITH TRIGEMINAL NEURALGIA; REINFORCES POTENTIAL AS ALTERNATIVE TO OPIOIDS AND SURGICAL INTERVENTIONS ELMSFORD, N.Y., July 24, 2018 (GLOBE NEWSWIRE) — NanoVibronix, Inc, (NASDAQ:NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced successful results for its PainShield™ device in treating patients…

NANOVIBRONIX ANNOUNCES EXCLUSIVE AGREEMENT FOR DISTRIBUTION OF PAINSHIELD® AND WOUNDSHIELD® IN ISRAEL ELMSFORD, N.Y., June 05, 2018 (GLOBE NEWSWIRE) — NanoVibronix, Inc., (NASDAQ:NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has entered into an exclusive agreement with M.D.S.…

NANOVIBRONIX PROVIDES BUSINESS UPDATE FOR THE FIRST QUARTER 2018 ELMSFORD, N.Y., May 17, 2018 (GLOBE NEWSWIRE) — NanoVibronix, Inc, (NASDAQ:NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today provided a business update for the first quarter of 2018. Brian…

NANOVIBRONIX PARTNERS WITH FABRICATION ENTERPRISES, INC. FOR DISTRIBUTION OF PAINSHIELD® IN THE UNITED STATES ELMSFORD, N.Y., May 09, 2018 (GLOBE NEWSWIRE) — NanoVibronix, Inc., (NASDAQ:NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has partnered with Fabrication Enterprises, Inc. to market and…

NANOVIBRONIX TO PRESENT AT THE 3RD ANNUAL DISRUPTIVE GROWTH & HEALTHCARE CONFERENCE HOSTED BY RHK CAPITAL AND REED SMITH NEW YORK, May 01, 2018 (GLOBE NEWSWIRE) — NanoVibronix, Inc., (NASDAQ:NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that it will be presenting at the 3rd annual Disruptive…

NANOVIBRONIX ANNOUNCES INSTRUMED SURGICAL AS ITS EXCLUSIVE CANADIAN DISTRIBUTOR FOR UROSHIELD(TM) ELMSFORD, NY — (Marketwired) — 04/05/18 — NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has signed Instrumed Surgical of Mississauga, Ontario, Canada as…

NANOVIBRONIX PROVIDES YEAR-END 2017 BUSINESS UPDATE AND FILES 10-K ELMSFORD, NY — (Marketwired) — 04/02/18 — NanoVibronix, Inc, (NASDAQ: NAOV) , a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today provided a business update for the year ended December 31, 2017.…

NANOVIBRONIX CEO BRIAN MURPHY AND FORMER YANKEES PITCHER MARIANO RIVERA APPEAR ON FOX NEWS RADIO’S THE BRIAN KILMEADE SHOW TO DISCUSS PAINSHIELD’S ADVANTAGES AND POTENTIAL TO REDUCE OPIOID USE ELMSFORD, NY — (Marketwired) — 03/21/18 — NanoVibronix Inc. (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that Brian Murphy, CEO of NanoVibronix and former Yankees…

NANOVIBRONIX CEO BRIAN MURPHY AND FORMER YANKEES PITCHER MARIANO RIVERA TO APPEAR ON FOX BUSINESS NETWORK’S MORNINGS WITH MARIA TO DISCUSS THE ROLE OF PAINSHIELD IN FIGHTING THE OPIOID EPIDEMIC ELMSFORD, NY — (Marketwired) — 03/21/18 — NanoVibronix, Inc, (NASDAQ: NAOV) , a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that Brian Murphy, CEO of NanoVibronix and former Yankees pitcher…

NANOVIBRONIX ANNOUNCES POSITIVE RESPONSE TO UROSHIELD(TM) PRESENTATION AT THE INFECTION PREVENTION AND CONTROL 2018 LONDON CONFERENC ELMSFORD, NY — (Marketwired) — 03/01/18 — NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology today announced that Dr. Harold Jacob, M.D., Chief Medical Officer of…

NANOVIBRONIX TO PRESENT AT THE 14TH ANNUAL NOBLE CAPITAL MARKETS INVESTOR CONFERENCE PRESENTATION SCHEDULED FOR MONDAY, JANUARY 29 AT 10:30AM EST ELMSFORD, NY — (Marketwired) — 01/22/18 — NanoVibronix, Inc, (NASDAQ: NAOV) , a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, will present at…

NANOVIBRONIX CEO BRIAN MURPHY APPEARS ON VARNEY & CO. ON FOX BUSINESS; COMMENTS ON ROLE OF PAINSHIELD IN FIGHTING OPIOID EPIDEMIC ELMSFORD, NY — (Marketwired) — 01/19/18 — NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that Brian Murphy, CEO of NanoVibronix, appeared as a…

NANOVIBRONIX ANNOUNCES EXPANDED AGREEMENT WITH MDS PHARM LTD. TO INCLUDE DISTRIBUTION OF UROSHIELD® IN ISRAEL ELMSFORD, N.Y., Dec. 27, 2018 (GLOBE NEWSWIRE) — NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has expanded its distribution agreement with…

NANOVIBRONIX SIGNS MAJOR DISTRIBUTOR IN INDIA FOR UROSHIELD® ELMSFORD, N.Y., Dec. 20, 2018 (GLOBE NEWSWIRE) — NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced, in partnership with Morulaa HealthTech, NanoVibronix’s marketing partner…

NANOVIBRONIX SIGNS WITH EXCLUSIVE DISTRIBUTOR IN SWITZERLAND FOR UROSHIELD® ELMSFORD, N.Y., Dec. 18, 2018 (GLOBE NEWSWIRE) — NanoVibronix, Inc, (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it has signed a new distribution agreement for…